No. of Pages: 229 | Report Code: TIPRE00023049 | Category: Life Sciences
市场介绍
聚合酶链式反应 (PCR) 用于准确的护理点诊断，有助于快速识别和诊断确定呼吸道感染的原因。此外，PCR 在住院和门诊环境中通常是首选，这有助于提高近年来市场的增长。当前SARS CoV2的爆发正在推动市场的增长。
市场概况和动态
欧洲呼吸道感染诊断 PCR 市场预计将从 2021 年的 12.4101 亿美元增至 2028 年的 24.3246 亿美元。预计 2021 年至 2028 年该市场将以 10.1% 的复合年增长率增长。呼吸道疾病（CRD）和 PCR 检测的不断发展预计将推动市场的增长。然而，替代检测的可用性是阻碍市场增长的主要因素。
关键细分市场
从类型来看，qPCR细分市场所占份额最高，预计未来将占据最大市场份额。该细分市场的增长主要是由其特性驱动的，例如巨大的动态范围、卓越的灵敏度、非常序列特异性的能力、很少甚至没有后扩增处理以及增加的样品通量。此外，PCR 类型的定期开发正在推动市场。
主要来源和上市公司
欧洲疾病预防和控制中心，欧洲药品该报告中包含了欧洲呼吸道感染诊断市场 PCR 的主要二级来源，其中包括机构、欧洲呼吸学会和食品药品管理局。
原因购买报告
欧洲呼吸道感染诊断 PCR 市场细分
按
类型
按产品类型
按感染类型
公司简介
Strategic insights for Europe PCR for Respiratory Infection Diagnostics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 1,241.01 Million |
| Market Size by 2028 | US$ 2,432.46 Million |
| Global CAGR (2021 - 2028) | 10.1% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 类型
|
| Regions and Countries Covered | 欧洲
|
| Market leaders and key company profiles |
The regional scope of Europe PCR for Respiratory Infection Diagnostics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The List of Companies - Europe PCR for Respiratory Infection Diagnostics Market
The Europe PCR for Respiratory Infection Diagnostics Market is valued at US$ 1,241.01 Million in 2021, it is projected to reach US$ 2,432.46 Million by 2028.
As per our report Europe PCR for Respiratory Infection Diagnostics Market, the market size is valued at US$ 1,241.01 Million in 2021, projecting it to reach US$ 2,432.46 Million by 2028. This translates to a CAGR of approximately 10.1% during the forecast period.
The Europe PCR for Respiratory Infection Diagnostics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe PCR for Respiratory Infection Diagnostics Market report:
The Europe PCR for Respiratory Infection Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe PCR for Respiratory Infection Diagnostics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe PCR for Respiratory Infection Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe PCR for Respiratory Infection Diagnostics Market
